dr. singh on dose dense acthp in her2 breast cancer
Published 4 years ago • 377 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:50
dr. hudis on dose-dense chemotherapy for breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
1:32
dr. verma on immunotherapy in her2 breast cancer
-
6:45
dr. shalini singh: diagnostic for metastatic breast cancer patients with low her2 expression
-
1:52
dr. murthy on de-escalation strategies in her2-positive breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
8:03
refining neoadjuvant chemotherapy for her2 breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
1:20
dr. barrio on treatment options for her2 breast cancer
-
0:51
dr. tripathy discusses immunotherapy in her2 breast cancer
-
1:44
dr. tripathy on the evolving treatment landscape of her2 breast cancer
-
1:16
dr. chagpar on surgical treatment of patients with her2 breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
1:14
dr. cheng on the role of t-dm1 in her2 breast cancer
-
1:24
dr. verma on treatments in the neoadjuvant setting of her2 breast cancer